Similar articles

• Generic antiretrovirals and HIV care in the United States.

  Cohn J. Cohn J. Ann Intern Med. 2013 May 21;158(10):777. doi: 10.7326/0003-4819-158-10-201305210-00017. Ann Intern Med. 2013. PMID: 23689771 No abstract available.
• Generic antiretrovirals and HIV care in the United States--in response.

  Sherer R. Sherer R. Ann Intern Med. 2013 May 21;158(10):777-8. doi: 10.7326/0003-4819-158-10-201305210-00018. Ann Intern Med. 2013. PMID: 23689772 No abstract available.
• The future of generic HIV drugs in Rhode Island.

  Lee JY, Reece R, Montague B, Rana A, Alexander-Scott N, Flanigan T. Lee JY, et al. R I Med J (2013). 2013 Sep 6;96(9):30-3. R I Med J (2013). 2013. PMID: 24015398
• Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
.

  Cattaneo D, Andreoni M, Carosi G, Cauda R, Lazzarin A, Rizzardini G. Cattaneo D, et al. Int J Clin Pharmacol Ther. 2017 May;55(5):381-393. doi: 10.5414/CP202775. Int J Clin Pharmacol Ther. 2017. PMID: 28211784 Review.
• Access to essential medications for HIV/AIDS in South Africa.

  Andrews S. Andrews S. S Afr Med J. 2001 May;91(5):384-7. S Afr Med J. 2001. PMID: 11455797 Review. No abstract available.